Invitrogen™ Human LRFN3 Synthetic Peptide

Catalog No.	Quantity
PEP0821	50 μg

Catalog No. PEP0821 Supplier Invitrogen™ Supplier No. PEP0821

Description

Synthetic Peptide

This peptide corresponds to 16 amino acids near the center of human LRFN3. PEP-0821 can be used as a blocking peptide with polyclonal antibody PA5-20706.

LRFN3 is one of a family of five transmembrane glycoproteins that are highly expressed in neuronal tissues. LRFN proteins share leucine-rich repeat (LRR)-immunoglobulin-like (Ig)-fibronectin type III (Fn)-transmembrane domain structure with other members of the LRR-Ig-Fn protein superfamily such as the Slitrk family of proteins. Expression of LRFN1, -3, and -4 mRNA was detected in embryonic neuronal cells, while Lrfn2 and Lrfn5 expression was primarily restricted to more mature cells. LRFN1, -2, and -4 bound to PDZ domains of postsynaptic PSD95, re-distributing PSD95 to the cell periphery. It has been suggested that the Lrfn proteins play a role in the developing and/or mature vertebrate nervous system.

Specifications

• Gene ID (Entrez): 79414
• Species: Human
• Purification Method: purified
• Accession Number: Q9BTN0
• Common Name: LRFN3
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Alias: A530045B06Rik; EMBL:AAI58863.1, ECO:0000312; fibronectin type III, immunoglobulin and leucine rich repeat domains 1; FIGLER1; leucine rich repeat and fibronectin type III domain containing 3; leucine-rich repeat and fibronectin type-III domain-containing protein 3; LRFN3; lrfn3 {ECO:0000312; PubMed:18227064}; RGD:1305567}; Salm4; Synaptic adhesion-like molecule 4; synaptic adhesion-like molecule 4 {ECO:0000303; UNQ5865/PRO34192
• Gene Symbol: LRFN3
• Lyophilized: No
• Preservative: Sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO
• Storage Buffer: PBS